Managers / Q1 2022 · view latest →
Birch Grove Capital LP
CIK 0001652355 · 590 MADISON AVENUE, 38TH FLOOR, NEW YORK, NY, 10022 · 212-753-7510
Summary
Birch Grove Capital LP reported $245M in U.S.-listed holdings across 38 positions for Q1 2022.
Its largest position, Tabula Rasa Healthcare, represents 9.4% of the portfolio.
Compared with Q4 2021, the fund opened 9 new positions and exited 18.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- US DOMESTIC · 86.4% · $211M
- Common Stock · 9.0% · $22M
- Other · 4.0% · $10M
- ETP · 0.7% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| THE REALREAL INC | NEW | +18.22M | 18.22M | +$14M | $14M |
| ENPHASE ENERGY INC | NEW | +12.68M | 12.68M | +$13M | $13M |
| SPOTIFY USA INC | NEW | +14.00M | 14.00M | +$12M | $12M |
| MAGNITE INC | NEW | +14.50M | 14.50M | +$12M | $12M |
| STARR GROUP HOLDINGS INC | NEW | +757.4K | 757.4K | +$9M | $9M |
| AERIE PHARMACEUTICALS INC | NEW | +8.00M | 8.00M | +$7M | $7M |
| PRECIGEN INC | NEW | +3.50M | 3.50M | +$3M | $3M |
| CHURCHILL CAPITAL CORP VI | NEW | +80.0K | 80.0K | +$50,000 | $50,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | TABULA RASA HEALTHCARE INC | NOTE 1.750% 2/1 | 9.37% | $23M | 30.38M |
| 2 | KAMAN CORP | NOTE 3.250% 5/0 · COM | 8.30% | $20M | 17.09M |
| 3 | SPLUNK INC | NOTE 1.125% 6/1 · NOTE 1.125% 9/1 | 8.04% | $20M | 19.05M |
| 4 | HERBALIFE LTD | NOTE 2.625% 3/1 | 7.11% | $17M | 18.54M |
| 5 | JAZZ INVESTMENTS I LTD | NOTE 1.500% 8/1 | 6.76% | $17M | 16.10M |
| 6 | NUVASIVE INC | NOTE 1.000% 6/0 · NOTE 0.375% 3/1 | 6.37% | $16M | 16.00M |
| 7 | UBER TECHNOLOGIES INC | NOTE 12/1 | 5.67% | $14M | 15.50M |
| 8 | THE REALREAL INC | NOTE 1.000% 3/0 | 5.52% | $14M | 18.22M |
| 9 | ENPHASE ENERGY INC | NOTE 3/0 | 5.29% | $13M | 12.68M |
| 10 | SPOTIFY USA INC | NOTE 3/1 | 4.89% | $12M | 14.00M |
| 11 | MAGNITE INC | NOTE 0.250% 3/1 | 4.73% | $12M | 14.50M |
| 12 | RINGCENTRAL INC | NOTE 3/1 | 3.71% | $9M | 11.00M |
| 13 | STARR GROUP HOLDINGS INC | CL A COM | 3.53% | $9M | 757.4K |
| 14 | RADIUS HEALTH INC | NOTE 3.000% 9/0 · COM NEW | 3.46% | $8M | 8.25M |
| 15 | NOTVQINOTIV INChistory → | COM | 3.17% | $8M | 296.1K |
| 16 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000% 10/1 | 3.08% | $8M | 9.00M |
| 17 | AERIE PHARMACEUTICALS INC | NOTE 1.500% 10/0 | 2.94% | $7M | 8.00M |
| 18 | DHTDHT HOLDINGS INChistory → | SHS NEW | 1.18% | $3M | 498.5K |
| 19 | SPIRIT AEROSYSTEMS HLDGS INC | COM CL A | 1.15% | $3M | 57.7K |
| 20 | PRECIGEN INC | NOTE 3.500% 7/0 | 1.12% | $3M | 3.50M |
| 21 | BCOBRINKS COhistory → | COM | 1.05% | $3M | 37.9K |
| 22 | OIO-I GLASS INC | COM | 0.99% | $2M | 183.2K |
| 23 | EVOLENT HEALTH INC | NOTE 3.500% 10/1 | 0.79% | $2M | 1.05M |
| 24 | ALTERYX INC | NOTE 1.000% 8/0 | 0.54% | $1M | 1.50M |
| 25 | MULTIPLAN CORPORATION | *W EXP 02/13/202 | 0.34% | $827,000 | 235.1K |
| 26 | SLQTSELECTQUOTE INC | COM | 0.10% | $239,000 | 85.7K |
| 27 | GOHEALTH INC | COM CL A | 0.08% | $186,000 | 157.7K |
| 28 | CHURCHILL CAPITAL CORP V | *W EXP 10/29/202 | 0.02% | $61,000 | 100.0K |
| 29 | CHURCHILL CAPITAL CORP VI | *W EXP 10/17/202 | 0.02% | $50,000 | 80.0K |
| 30 | CHURCHILL CAPITAL CORP VII | UNIT 99/99/9999 | 0.02% | $48,000 | 80.0K |
| 31 | SKILLSOFT CORP | *W EXP 06/11/202 | 0.02% | $39,000 | 33.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $10M | 3 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $10M | 4 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $13M | 6 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $23M | 9 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $57M | 12 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $68M | 13 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023REVEALED | $110M | 20 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $202M | 33 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $256M | 41 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $252M | 41 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $245M | 38 | May 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $221M | 47 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $212M | 52 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $206M | 46 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $230M | 50 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $192M | 40 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $185M | 46 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $121M | 43 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $70M | 13 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $81M | 16 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $135M | 29 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $131M | 13 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $166M | 23 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $222M | 28 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.